Identification Generic Name (1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE DrugBank Accession Number DB08280 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE (DB08280) ×  Close Weight Average: 386.4846  Monoisotopic: 386.220557458  Chemical Formula C 22 H 30 N 2 O 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Corticosteroid 11-beta-dehydrogenase isozyme 1 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as anisoles. These are organic compounds containing a methoxybenzene or a derivative thereof. Kingdom Organic compounds Super Class Benzenoids Class Phenol ethers Sub Class Anisoles Direct Parent Anisoles Alternative Parents Phenoxy compounds  /  Methoxybenzenes  /  Alkyl aryl ethers  /  Secondary carboxylic acid amides  /  Primary carboxylic acid amides  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds Substituents Alkyl aryl ether  /  Anisole  /  Aromatic homopolycyclic compound  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Ether  /  Hydrocarbon derivative  /  Methoxybenzene  /  Monocyclic benzene moiety Molecular Framework Aromatic homopolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key MNVKIDPRYUGTTG-YINOZDTMSA-N InChI InChI=1S/C22H30N2O4/c1-21(2,28-17-6-4-16(27-3)5-7-17)20(26)24-18-14-8-13-9-15(18)12-22(10-13,11-14)19(23)25/h4-7,13-15,18H,8-12H2,1-3H3,(H2,23,25)(H,24,26)/t13-,14-,15+,18-,22- IUPAC Name (1s,3R,4s,5S,7s)-4-[2-(4-methoxyphenoxy)-2-methylpropanamido]adamantane-1-carboxamide SMILES [H][C@@]12C[C@@]3([H])C[C@@](C1)(C[C@@]([H])(C2)[C@@]3([H])NC(=O)C(C)(C)OC1=CC=C(OC)C=C1)C(N)=O References General References Not Available External Links PubChem Compound 15942677 PubChem Substance 99444751 ChemSpider 26328288 ZINC ZINC000100036578 PDBe Ligand NN4 PDB Entries 2irw Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0117 mg/mL ALOGPS logP 2.84 ALOGPS logP 2.41 Chemaxon logS -4.5 ALOGPS pKa (Strongest Acidic) 14.84 Chemaxon pKa (Strongest Basic) -0.44 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 90.65 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 104.46 m 3 ·mol -1 Chemaxon Polarizability 42.33 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9875 Blood Brain Barrier - 0.532 Caco-2 permeable - 0.6224 P-glycoprotein substrate Substrate 0.5264 P-glycoprotein inhibitor I Non-inhibitor 0.6845 P-glycoprotein inhibitor II Inhibitor 0.5569 Renal organic cation transporter Non-inhibitor 0.9406 CYP450 2C9 substrate Non-substrate 0.8427 CYP450 2D6 substrate Non-substrate 0.8001 CYP450 3A4 substrate Substrate 0.6545 CYP450 1A2 substrate Non-inhibitor 0.8352 CYP450 2C9 inhibitor Non-inhibitor 0.6939 CYP450 2D6 inhibitor Non-inhibitor 0.9424 CYP450 2C19 inhibitor Non-inhibitor 0.8079 CYP450 3A4 inhibitor Non-inhibitor 0.7223 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7394 Ames test Non AMES toxic 0.6802 Carcinogenicity Non-carcinogens 0.8633 Biodegradation Not ready biodegradable 0.9918 Rat acute toxicity 2.3978 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9983 hERG inhibition (predictor II) Non-inhibitor 0.8441    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Corticosteroid 11-beta-dehydrogenase isozyme 1 Kind Protein Organism Humans Pharmacological action Unknown General Function 11-beta-hydroxysteroid dehydrogenase [nad(p)] activity Specific Function Catalyzes reversibly the conversion of cortisol to the inactive metabolite cortisone. Catalyzes reversibly the conversion of 7-ketocholesterol to 7-beta-hydroxycholesterol. In intact cells, the rea... Gene Name HSD11B1 Uniprot ID P28845 Uniprot Name Corticosteroid 11-beta-dehydrogenase isozyme 1 Molecular Weight 32400.665 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:30 / Updated at June 12, 2020 16:52 